Charles Schwab’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.28M | Buy |
435,516
+11,254
| +3% | +$84.7K | ﹤0.01% | 2506 |
|
|
2025
Q1 | $3.21M | Sell |
424,262
-6,709
| -2% | -$50.8K | ﹤0.01% | 2457 |
|
|
2024
Q4 | $5.25M | Buy |
430,971
+7,012
| +2% | +$85.4K | ﹤0.01% | 2315 |
|
|
2024
Q3 | $7.1M | Buy |
423,959
+53,328
| +14% | +$893K | ﹤0.01% | 2192 |
|
|
2024
Q2 | $6.46M | Buy |
370,631
+112,758
| +44% | +$1.97M | ﹤0.01% | 2238 |
|
|
2024
Q1 | $4.39M | Buy |
257,873
+11,168
| +5% | +$190K | ﹤0.01% | 2332 |
|
|
2023
Q4 | $2.51M | Buy |
246,705
+16,719
| +7% | +$170K | ﹤0.01% | 2544 |
|
|
2023
Q3 | $2.08M | Buy |
229,986
+44,200
| +24% | +$400K | ﹤0.01% | 2584 |
|
|
2023
Q2 | $2M | Sell |
185,786
-1,747
| -0.9% | -$18.8K | ﹤0.01% | 2547 |
|
|
2023
Q1 | $1.92M | Sell |
187,533
-33,033
| -15% | -$338K | ﹤0.01% | 2536 |
|
|
2022
Q4 | $2.33M | Buy |
220,566
+3,028
| +1% | +$31.9K | ﹤0.01% | 2520 |
|
|
2022
Q3 | $2.79M | Buy |
217,538
+31,765
| +17% | +$407K | ﹤0.01% | 2480 |
|
|
2022
Q2 | $2.38M | Buy |
185,773
+7,623
| +4% | +$97.7K | ﹤0.01% | 2516 |
|
|
2022
Q1 | $1.87M | Buy |
178,150
+3,937
| +2% | +$41.2K | ﹤0.01% | 2667 |
|
|
2021
Q4 | $2.69M | Buy |
174,213
+3,469
| +2% | +$53.5K | ﹤0.01% | 2601 |
|
|
2021
Q3 | $3.85M | Buy |
170,744
+81,045
| +90% | +$1.83M | ﹤0.01% | 2489 |
|
|
2021
Q2 | $2.31M | Buy |
89,699
+3,268
| +4% | +$84.2K | ﹤0.01% | 2667 |
|
|
2021
Q1 | $3.6M | Buy |
+86,431
| New | +$3.6M | ﹤0.01% | 2450 |
|